Laura A N Peferoen (Laura Peferoen)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Leon J Wils, Marijke Buijze, Marijke Stigter van Walsum, Arjen Brink, Britt E van Kempen, Laura A N Peferoen, Elisabeth R Brouns, Jan G A M de Visscher, Erik H van der Meij, Elisabeth Bloemena, Jos B Poell, Ruud H Brakenhoff
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells 13 (8) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Leon J Wils, Marijke Buijze, Marijke Stigter van Walsum, Arjen Brink, Britt E van Kempen, Laura A N Peferoen, Elisabeth R Brouns, Jan G A M de Visscher, Erik H van der Meij, Elisabeth Bloemena, Jos B Poell, Ruud H Brakenhoff
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells 13 (8) (2024)
Leon J Wils, Marijke Buijze, Marijke Stigter van Walsum, Arjen Brink, Britt E van Kempen, Laura A N Peferoen, Elisabeth R Brouns, Jan G A M de Visscher, Erik H van der Meij, Elisabeth Bloemena, Jos B Poell, Ruud H Brakenhoff
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells 13 (8) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Ilkay Evren, Ahmad M Najim, Jos B Poell, Elisabeth R Brouns, Leon J Wils, Laura A N Peferoen, Ruud H Brakenhoff, Elisabeth Bloemena, Erik H van der Meij, Jan G A M de Visscher
The value of regular follow-up of oral leukoplakia for early detection of malignant transformation. Oral diseases (2023)